viewBushveld Minerals Ltd

Bushveld Minerals forms new vanadium financing partnership with redT

Bushveld has built up a strong track record in the vanadium space

Bushveld Minerals Ltd -

Bushveld Minerals Ltd (LON:BMN)(OTCMKTS:BSHVF) has signed a joint venture agreement with redT energy PLC (LON:RED) to form a vanadium financing partnership to supply vanadium electrolyte for third party-owned vanadium redox flow batteries in projects developed by redT.

A key part of Bushveld's strategy is to encourage the growth of the market for vanadium redox flow batteries, an attractive commercial opportunity in itself, which will also help strengthen vanadium demand profile.

The partnership will take the form of a special-purpose vehicle structured to hold physical vanadium. It will supply vanadium electrolyte, an important element of vanadium redox flow batteries, to a series of projects in Europe to be deployed over an initial period of two years.

The deal builds on the smaller contract executed in 2019 in the USA with Avalon Battery Corporation.

The partnership's initial target will be to deliver approximately 15 MWh of vanadium redox flow batteries to market.

This will require approximately 80 metric tonnes of vanadium to be supplied by Bushveld.

The vanadium electrolyte will be supplied to the projects via long-term lease or rental arrangements, with financing from external funders that the Partnership are currently in discussions with.

Quick facts: Bushveld Minerals Ltd

Price: 13.95 GBX

Market: LSE
Market Cap: £160.84 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Bushveld Minerals Ltd named herein, including the promotion by the Company of Bushveld Minerals Ltd in any Content on the Site, the Company...



Investor Update: hVIVO’s mosquito vaccine moves into the clinic

Headlines from the Proactive Investors UK newsroom.  Clinical services group hVIVO’s (LON:HVO) experimental vaccine AGS-v PLUS is to undergo a phase 1 safety trial at the University of Maryland school of medicine. The vaccine is designed to protect against mosquito-borne diseases such as...

on 07/31/2019

2 min read